Home › Type 2 Diabetes › Texas › Dallas

Pag-aaral pangklinika para sa Type 2 Diabetes sa Dallas, TX

Isang pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Nagre-recruitPhase 3

University of Texas Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Nagre-recruitPhase 3

Soltero Cardiovascular Research Center, Dallas
North Texas Endocrine Center, Dallas
Southwest Family Medicine Associates, Dallas
at 1 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07064473

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Nagre-recruitPhase 3

Velocity Clinical Research, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07351058

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Nagre-recruitPhase 3

Velocity Clinical Research, Dallas, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07282600

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Nagre-recruitPhase 3

Research Site, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07662109

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Nagre-recruitPhase 2

M3 Wake Research Dallas - Internal Medicine, Dallas
Revival Research Institute, LLC, Dallas

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Nagre-recruitPhase 3

Research Site, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07662213

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Nagre-recruitPhase 2

Zenos Clinical Research, Dallas

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07502508

The RESET System Pivotal Clinical Trial (Protocol Revision K)

Nagre-recruit

M3 Wake Research, Dallas

Edad 22 hanggang 65 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT04101669

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Nagre-recruitPhase 2

Velocity Clinical Research - Dallas, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT07296484

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Nagre-recruitPhase 3

North Texas Endocrine Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07817251

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Nagre-recruit

University of Texas Southwestern Medical Center, Dallas
Parkland Health & Hospital System (PHHS), Dallas
Baylor Scott and White - Health System, Dallas

Lahat ng edad · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06593327

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Nagre-recruitPhase 2

University of Texas Southwestern Medical Center, Dallas

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07415954

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Nagre-recruitPhase 3

Thyroid Endocrinology & Diabetes PA, Dallas
Baylor Jack and Jane Hamilton, Dallas

Edad 45 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07797335

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Nagre-recruitPhase 3

Research Institute of Dallas, Dallas

Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06739122

Polypill for Prevention of Cardiomyopathy

Nagre-recruitPhase 1/2

UT Southwestern Medical Center, Dallas

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06143566

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Nagre-recruitPhase 2

Velocity Clinical Research Dallas, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT07546929

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Nagre-recruit

UT Southwestern Medical Center, Dallas

Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Peb 10, 2026 · NCT05168605

Pag-aaral para sa Type 2 Diabetes sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.